R Bedimo

Summary

Country: USA

Publications

  1. ncbi Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era
    Roger J Bedimo
    VA North Texas Health Care System, University of Texas Southwestern Medical Center, Dallas, Texas 75216, USA
    Clin Infect Dis 53:84-91. 2011
  2. ncbi Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002
    Roger Bedimo
    University of Alabama at Birmingham, USA
    Clin Infect Dis 39:1380-4. 2004
  3. ncbi Sustained HIV viral suppression following treatment interruption: an observational study
    Roger Bedimo
    University of Alabama, Birmingham, Alabama 85294, USA
    AIDS Res Hum Retroviruses 22:40-4. 2006
  4. ncbi Lipid abnormalities in HIV/hepatitis C virus-coinfected patients
    R Bedimo
    Department of Medicine, Division of Infectious Diseases, University of Texas South western Medical Center at Dallas, Dallas, TX 75216, USA
    HIV Med 7:530-6. 2006
  5. ncbi Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients
    R Bedimo
    Department of Medicine, VA North Texas Health Care System, Dallas, 75216, USA
    HIV Med 11:462-8. 2010
  6. ncbi Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus
    Sean T Nguyen
    Texas Tech University Health Sciences Center School of Pharmacy, Dallas Fort Worth Regional Campus, Dallas, Texas 75216, USA
    Pharmacotherapy 28:323-30. 2008
  7. ncbi Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapy
    Anita P Rahman
    School of Pharmacy, Texas Tech University Health Sciences Center, Dallas Fort Worth Regional Campus, Dallas, Texas 75216, USA
    Pharmacotherapy 28:913-9. 2008
  8. ncbi Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era
    Roger Bedimo
    VA North Texas Health Care System and University of Texas Southwestern Medical Center, 4500 South Lancaster Road, Dallas, TX 75216, USA
    Curr HIV/AIDS Rep 5:140-9. 2008
  9. ncbi Improvement in insulin sensitivity and dyslipidemia in protease inhibitor-treated adult male patients after switch to atazanavir/ritonavir
    Anthony J Busti
    Texas Tech University Health Sciences Center School of Pharmacy, Dallas, Texas, USA
    J Investig Med 56:539-44. 2008
  10. ncbi The management of musculoskeletal infection in HIV carriers
    Jean Bahebeck
    University Hospitals of Yaoundé, Cameroon
    Acta Orthop Belg 70:355-60. 2004

Collaborators

Detail Information

Publications10

  1. ncbi Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era
    Roger J Bedimo
    VA North Texas Health Care System, University of Texas Southwestern Medical Center, Dallas, Texas 75216, USA
    Clin Infect Dis 53:84-91. 2011
    ..Some studies have suggested that exposure to antiretroviral therapy (ART) with abacavir is associated with an increased risk of acute myocardial infarction (AMI)...
  2. ncbi Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002
    Roger Bedimo
    University of Alabama at Birmingham, USA
    Clin Infect Dis 39:1380-4. 2004
    ..87; P<.0002). The mean CD4 cell count was lower among patients with ADMs than among those with non-ADMs. A longer duration of survival during highly active antiretroviral therapy might explain the increasing incidence of non-ADMs...
  3. ncbi Sustained HIV viral suppression following treatment interruption: an observational study
    Roger Bedimo
    University of Alabama, Birmingham, Alabama 85294, USA
    AIDS Res Hum Retroviruses 22:40-4. 2006
    ..Examining the immune responses of nonrebounders may contribute to the understanding of protective immunity to HIV...
  4. ncbi Lipid abnormalities in HIV/hepatitis C virus-coinfected patients
    R Bedimo
    Department of Medicine, Division of Infectious Diseases, University of Texas South western Medical Center at Dallas, Dallas, TX 75216, USA
    HIV Med 7:530-6. 2006
    ..Among HIV-infected patients, hepatitis C virus (HCV) coinfection is associated with increased rates of lipodystrophy and insulin resistance. Its impact on HIV-associated dyslipidaemia is less clear...
  5. ncbi Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients
    R Bedimo
    Department of Medicine, VA North Texas Health Care System, Dallas, 75216, USA
    HIV Med 11:462-8. 2010
    ..Among HIV-infected patients, hepatitis C virus (HCV) coinfection is associated with lower cholesterol levels, but it remains unclear how it affects cardiovascular outcomes...
  6. ncbi Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus
    Sean T Nguyen
    Texas Tech University Health Sciences Center School of Pharmacy, Dallas Fort Worth Regional Campus, Dallas, Texas 75216, USA
    Pharmacotherapy 28:323-30. 2008
    ....
  7. ncbi Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapy
    Anita P Rahman
    School of Pharmacy, Texas Tech University Health Sciences Center, Dallas Fort Worth Regional Campus, Dallas, Texas 75216, USA
    Pharmacotherapy 28:913-9. 2008
    ....
  8. ncbi Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era
    Roger Bedimo
    VA North Texas Health Care System and University of Texas Southwestern Medical Center, 4500 South Lancaster Road, Dallas, TX 75216, USA
    Curr HIV/AIDS Rep 5:140-9. 2008
    ....
  9. ncbi Improvement in insulin sensitivity and dyslipidemia in protease inhibitor-treated adult male patients after switch to atazanavir/ritonavir
    Anthony J Busti
    Texas Tech University Health Sciences Center School of Pharmacy, Dallas, Texas, USA
    J Investig Med 56:539-44. 2008
    ..However, its effects on insulin sensitivity have not been elucidated. We conducted this study to test the hypothesis that ATV improves insulin resistance and dyslipidemia...
  10. ncbi The management of musculoskeletal infection in HIV carriers
    Jean Bahebeck
    University Hospitals of Yaoundé, Cameroon
    Acta Orthop Belg 70:355-60. 2004
    ..For those who are MID, the indication for antiretroviral therapy should depend on the presence of one or more AIDS-related signs...